These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 3109089

  • 1. Valproate for epilepsy in renal transplant recipients receiving cyclosporine.
    Hillebrand G, Castro LA, van Scheidt W, Beukelmann D, Land W, Schmidt D.
    Transplantation; 1987 Jun; 43(6):915-6. PubMed ID: 3109089
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract] [Full Text] [Related]

  • 6. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W, Venkat KK, Florence-Green D, Norris C, Oh HK, Dienst S, Levin NW.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract] [Full Text] [Related]

  • 7. The impact of transplant aspiration cytology on management of cyclosporine A-treated renal transplant recipients.
    Yussim A, Shapira Z, Shmueli D, Heilbronn YD, Kaufman L, Servadio C.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1658-9. PubMed ID: 3274399
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Measurement of cyclosporine bioactivity in serum of renal transplant recipients: development and comparison with RIA.
    Heidecke CD, Nicolaus C, Stadler J, Florack G, Bollschweiler E, Hölscher M.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1734-6. PubMed ID: 3274418
    [No Abstract] [Full Text] [Related]

  • 10. Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test. A prospective study in renal transplant recipients.
    Turgeon DK, Leichtman AB, Blake DS, Schmouder RL, Lown KS, Annesley TM, Watkins PB.
    Transplantation; 1994 Jun 27; 57(12):1736-41. PubMed ID: 8016878
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Divalproex and epilepsy.
    Willmore LJ.
    Psychopharmacol Bull; 2003 Jun 27; 37 Suppl 2():43-53. PubMed ID: 15021860
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cyclosporin-nicardipine interaction in the kidney-transplant patient].
    Kessler M, Renoult E, Jonon B, Vigneron B, Cao Huu T, Netter P.
    Therapie; 1987 Jun 27; 42(3):273-5. PubMed ID: 3310316
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum valproate levels with oral contraceptive use.
    Herzog AG, Farina EL, Blum AS.
    Epilepsia; 2005 Jun 27; 46(6):970-1. PubMed ID: 15946343
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative study of valproic acid and sodium valproate (author's transl)].
    Sorel L, Rucquoy-Ponsar M, Willems C, Diepart E, Harmant J.
    Acta Neurol Belg; 1981 Jun 27; 81(5):283-90. PubMed ID: 6797226
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.